Gain insights into bioscience, technology and the quest to improve human health.
Settings
Save and close
Gain insights into bioscience, technology and the quest to improve human health.
From genomic medicine to AI-driven discoveries, JAX continues to revolutionize biomedical research, drug discovery, and precision healthcare.
Combining genetic therapy and bone marrow transplantation may offer comprehensive treatment solution for multiple sulfatase deficiency.
The AI-powered home-cage monitoring solution is poised to enhance preclinical research efficiency and improve the translation of findings to clinical settings
Healthcare leaders and executives in Maine selected to guide governor on AI innovation and workforce development.
Mice with a genetically pure background are susceptible to severe SARS-CoV-2 infection
Endometriosis is a complicated disease that affects 1 in 10 women. It can produce multiple, seemingly unrelated, symptoms, treatments are very limited, and patients often don’t receive a diagnosis for years after symptoms first appear.
Researchers at The Jackson Laboratory are part of multi-disciplinary teams that won $60 million in ARPA-H funding to study 3-D tumor models and personalized drugs
Researchers from the Rare Disease Translational Center joined family members and advocates for a panel focused on rare disease mouse modeling.
Researchers at The Jackson Laboratory have developed a new combination of imaging and computational methods to study connections between immune cells in breast cancer and melanoma
Researchers at The Jackson Laboratory (JAX), the Broad Institute of MIT and Harvard, and Yale University, have used artificial intelligence to design thousands of new DNA switches that can precisely control the expression of a gene in different cell types.
Researchers at The Jackson Laboratory conduct pivotal study into aging and lifespan to uncover new details about how diets might make people live longer — but also their negative side effects.